Literature DB >> 9514699

Reductions in the activation of ERK and JNK are associated with decreased IL-2 production in T cells from elderly humans stimulated by the TCR/CD3 complex and costimulatory signals.

B Liu1, K W Carle, R L Whisler.   

Abstract

T cells from elderly humans often display impaired IL-2 production, but the mechanisms are unknown. Because the activities of extracellular signal-regulated kinases (ERK) and c-Jun NH2-terminal kinases (JNK) are important for IL-2 production, the current study evaluated if aberrancies in the expression and activation of ERK2 or JNK might underlie decreased IL-2 production by human T cells during aging. The present results show that diminished ERK2 and JNK catalytic activities were commonly detected in T cells from elderly humans stimulated with anti-CD3 mAb OKT3 plus PMA. These reductions did not represent temporal shifts in activation or altered expression of ERK2 or JNK. In addition, the reductions of ERK2 activation in stimulated T cells from elderly individuals were accompanied by decreased Raf-1 kinase activation and could be observed without coexisting impairments in JNK activation. Stimulation of ERK2 activation in elderly T cells correlated with IL-2 production and decreased ERK2 activation was consistently associated with reduced IL-2 production. Although the age-related decreases in JNK activation were accompanied by reduced IL-2 production, substantial impairments of JNK activation were observed with diminished ERK2 activation. Moreover, anti-CD3/PMA-stimulated T cells from elderly individuals that displayed normal JNK activation and impaired ERK2 activation continued to demonstrate reduced IL-2 production. These findings show that impairments in the activation of ERK2 and JNK can accompany decreased IL-2 production by T cells from elderly humans and further suggest that aberrancies in TCR/CD3-dependent activation of the Raf-1/MEK/ERK2 cascade may be rate-limiting for the full induction of IL-2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9514699     DOI: 10.1006/cimm.1997.1226

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.

Authors:  J-X Wang; W Tang; L-P Shi; J Wan; R Zhou; J Ni; Y-F Fu; Y-F Yang; Y Li; J-P Zuo
Journal:  Br J Pharmacol       Date:  2007-01-29       Impact factor: 8.739

Review 2.  T-cell aging in end-stage renal disease: an evolving story with CMV.

Authors:  TienYu Owen Yang; Yi-Fang Chuang; Yen-Ling Chiu
Journal:  Med Microbiol Immunol       Date:  2019-03-21       Impact factor: 3.402

3.  Peripheral residence of naïve CD4 T cells induces MHC class II-dependent alterations in phenotype and function.

Authors:  Sanket Rane; Rituparna Das; Vidya Ranganathan; Savit Prabhu; Arundhoti Das; Hamid Mattoo; Jeannine Marie Durdik; Anna George; Satyajit Rath; Vineeta Bal
Journal:  BMC Biol       Date:  2014-12-21       Impact factor: 7.431

4.  pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients.

Authors:  Ling Huang; Nicolle H R Litjens; Nynke M Kannegieter; Mariska Klepper; Carla C Baan; Michiel G H Betjes
Journal:  Immun Ageing       Date:  2017-06-19       Impact factor: 6.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.